ReNATURE Labs Information

Renature Labs helps solve chronic diseases by transforming peptides into modern therapeutic treatments - orally ingestible, targeted and bio-available. We achieve this using our patented bio-technology platform which protects and delivers peptides when ingested orally, slowly releasing them over time at specified dosage profiles within the human body. An Australian based bio-technology company passionate about improving human health, in particular autoimmune diseases which are an emerging epidemic, increasing by 15% world wide, every year, over the past 30 years – Diabetes, crohns disease, and multiple sclerosis to name a few. We believe in a world where autoimmune diseases are no longer increasing, and we aim to make this a reality with our patented therapeutic peptide delivery platform. What Are Therapeutic Peptides? Peptides are the organic building blocks of life. They are simply chains of amino acids found within all living organisms, responsible for carrying out vital functions to sustain life. A Vast Universe of Peptides With millions of new peptides being discovered in corals, plants, insects and humans, scientists are only just starting to map out the landscape of peptide therapeutics and their immense potential for human health. Solving The Problem Of Peptide Delivery Despite the widely accepted health benefits of peptides, they are incredibly fragile. This results in the problem of peptide degradation preventing the health benefit from being realised. In fact, 86% of all peptides currently on the market must be injected due to this common problem. For example, people with life threatening diseases such as diabetes rely on daily injections of the peptide insulin to stay alive. Due to it's unstable state it must be injected and cannot be taken orally. Our patented platform technology developed by Dr. Alistair Laos solves the problem of peptide degradation. This opens new consumer and pharmaceutical markets, previously untapped.